Vaxart, Inc. (VXRT) stock
VXRTOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.48+0.02 (+5.04%)
Close on Oct 19, 2026Market cap $115.61MP/E 4.0Yield –
Vaxart enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Vaxart's enterprise value was $51.47M on Oct 19, 2026, against $50.29M a year earlier. Over the last 5 years it ranged from $6.29M to $809.68M, with a median of $81.57M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Oct 19, 2026 | $51.47M | +1.9% |
| 2025 | Dec 31, 2025 | $50.51M | -45.0% |
| 2024 | Dec 31, 2024 | $91.91M | +173.0% |
| 2023 | Dec 29, 2023 | $33.66M | +299.2% |
| 2022 | Dec 30, 2022 | $8.43M | -98.6% |
| 2021 | Dec 31, 2021 | $597.93M | +1.1% |
| 2020 | Dec 31, 2020 | $591.63M | – |
| 2019 | Dec 31, 2019 | -$3.38M | – |
| 2018 | Dec 31, 2018 | -$2.18M | -101.3% |
| 2017 | Dec 29, 2017 | $173.58M | -61.8% |
| 2016 | Dec 30, 2016 | $454.11M | -40.9% |
| 2015 | Dec 31, 2015 | $768.01M | -4.7% |
| 2014 | Dec 31, 2014 | $806.09M | -35.3% |
| 2013 | Dec 31, 2013 | $1.25B | +31.2% |
| 2012 | Dec 31, 2012 | $949.80M | -84.7% |
| 2011 | Dec 30, 2011 | $6.22B | -67.7% |
| 2010 | Dec 31, 2010 | $19.29B | – |
See a number that looks wrong?